Dr Betty Dube's Outputs (2)

Lessons learned: exploring equitable access to healthcare with Black, Asian and Global Ethnic Majority women in Aberdeen. (2024)
Presentation / Conference Contribution
NESHAT-MOKADEM, L., DUBE, B. and KERR, A. 2024. Lessons learned: exploring equitable access to healthcare with Black, Asian and Global Ethnic Majority women in Aberdeen. Presented at the 2024 NHS Research Scotland and Chief Scientist Office patient and public involvement event, 12 March 2024, Dundee, UK. Hosted on NHS Research Scotland [online]. Available from: https://www.nhsresearchscotland.org.uk/uploads/tinymce/Exploring%20Equitable%20Access%20to%20Healthcare%20.pdf

This presentation covers the lessons learned from a research project that sought to establish a diverse, collaborative panel consisting of members of the public, academics and third-party sector representatives. This panel was established with a view... Read More about Lessons learned: exploring equitable access to healthcare with Black, Asian and Global Ethnic Majority women in Aberdeen..

Semaglutide for weight loss. (2021)
Journal Article
OJENIRAN, M., DUBE, B., PAIGE, A., TON, J. and LINDBLAD, A.J. 2021. Semaglutide for weight loss. Canadian family physician [online], 67(11), page 842. Available from: https://doi.org/10.46747/cfp.6711842

Is semaglutide (SGT) effective for weight loss? Used with lifestyle changes, 2.4 mg of subcutaneous SGT weekly resulted in a mean 10% to 15% weight loss (10 to 15 kg) over 68 weeks versus 2% to 3% (3 to 4 kg) with placebo (PC). Most (70% to 80%) lost... Read More about Semaglutide for weight loss..